» Articles » PMID: 19740706

Innate Immune Signals in Atherosclerosis

Overview
Journal Clin Immunol
Date 2009 Sep 11
PMID 19740706
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is a chronic disease characterised by lipid retention and inflammation in the arterial intima. Innate immune mechanisms are central to atherogenesis, involving activation of pattern-recognition receptors (PRRs) and induction of inflammatory processes. In a complex tissue, such as the atherosclerotic lesion, innate signals can originate from several sources and promote atherogenesis through ligation of PRRs. The receptors recognise conserved molecular patterns on pathogens and endogenous products of tissue injury and inflammation. Activation of PRRs might affect several aspects of atherosclerosis by acting on lesion resident cells. Scavenger receptors mediate antigen uptake and clearance of lipoproteins, thereby promoting foam cell formation. Signalling receptors, such as Toll-like receptors (TLRs), lead to induction of pro-inflammatory cytokines and antigen-specific immune responses. In this review we describe the innate mechanisms present in the plaque. We focus on TLRs, their cross-talk with other PRRs, and how their signalling cascades influence inflammation within the atherosclerotic lesion.

Citing Articles

Time-frequency analysis reveals an association between the specific nuclear magnetic resonance (NMR) signal properties of serum samples and arteriosclerotic lesion progression in a diabetes mouse model.

Yui K, Kanawaku Y, Morita A, Hirakawa K, Cui F PLoS One. 2024; 19(3):e0299641.

PMID: 38457384 PMC: 10923453. DOI: 10.1371/journal.pone.0299641.


Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease.

Gold M, Woods E, Pobee D, Ibrahim R, Quyyumi A Curr Cardiol Rep. 2023; 25(12):1811-1821.

PMID: 38079057 DOI: 10.1007/s11886-023-01995-3.


Acute Coronary Syndrome: Disparities of Pathophysiology and Mortality with and without Peripheral Artery Disease.

Gherasie F, Popescu M, Bartos D J Pers Med. 2023; 13(6).

PMID: 37373933 PMC: 10301808. DOI: 10.3390/jpm13060944.


Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia.

Sobolevskaya E, Shumkov O, Smagin M, Guskov A, Malysheva A, Atuchin V Int J Mol Sci. 2023; 24(10).

PMID: 37240440 PMC: 10219416. DOI: 10.3390/ijms24109096.


Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials.

Scisciola L, Cataldo V, Taktaz F, Fontanella R, Pesapane A, Ghosh P Front Cardiovasc Med. 2022; 9:1008922.

PMID: 36148061 PMC: 9485634. DOI: 10.3389/fcvm.2022.1008922.